{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T07:11:36Z","timestamp":1774422696602,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Fibromyalgia a common idiopathic condition affecting around 1.4% of adults globally. Its signature symptom is chronic widespread pain, with a constellation of somatic and psychological symptoms. Fibromyalgia is associated with significant reductions in quality of life, yet to date there is no biochemical marker for its diagnosis. Previous studies have indicated a strong association with gastrointestinal dysfunction, and more recently, alterations to the gut microbiome. No studies have examined the inter-relationship between fibromyalgia, gastrointestinal dysfunction, and the microbiome. This prospective observational case-controlled study will gather data on gastrointestinal function, dietary intake, fermentation patterns of ingested carbohydrates, and symptoms commonly associated with fibromyalgia. These will be evaluated alongside human gene expression and metatranscriptomic analysis of the oral and faecal microbiome.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Adult women aged\u2009\u226518\u2009years diagnosed with fibromyalgia and\/or meeting ACR 2016 criteria, and healthy family or age-matched controls will be recruited from the community. From consenting participants, we will collect detailed survey information and samples of blood, urine, stool, saliva, and breath.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This is the first prospective study examining interactions between digestive function, human gene expression, and the gut microbiome together with general, and fibromyalgia-specific, symptoms experienced by New Zealand women. This exploration will allow an in-depth understanding of clinically relevant factors that are associated with fibromyalgia and will guide further research and contribute to improved management of this poorly understood condition.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial Registration<\/jats:title>\n                <jats:p>The study was approved by the New Zealand Health and Disability Committee (HDEC) (ref: 20\/CEN\/197) and registered with the Australia and New Zealand Clinical Trials Registry (ANZCTR), registration number ACTRN12620001337965. Written consent will be obtained after providing participants with detailed information about the procedures. Access to data will be restricted to the immediate research team, and all samples and survey data will be deidentified and coded before analysis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-023-06259-3","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T07:03:04Z","timestamp":1677481384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Investigating the association between the symptoms of women with Fibromyalgia, Digestive function, and markers of the microbiota of the Gastrointestinal Tract (The FIDGIT Study): study protocol"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8448-5644","authenticated-orcid":false,"given":"Sharon","family":"Erdrich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason A","family":"Hawrelak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen P","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Momchilo","family":"Vuyisich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna E","family":"Harnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,27]]},"reference":[{"issue":"5","key":"6259_CR1","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s11916-996-0010-6","volume":"8","author":"F Inanici","year":"2004","unstructured":"Inanici F, Yunus MB. History of fibromyalgia: past to present. Curr Pain Headache Rep. 2004;8(5):369\u201378. https:\/\/doi.org\/10.1007\/s11916-996-0010-6.","journal-title":"Curr Pain Headache Rep."},{"issue":"3","key":"6259_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","volume":"46","author":"F Wolfe","year":"2016","unstructured":"Wolfe F, Clauw DJ, Fitzcharles M-A, Goldenberg DL, H\u00e4user W, Katz RL, et al. 2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46(3):319\u201329. https:\/\/doi.org\/10.1016\/j.semarthrit.2016.08.012.","journal-title":"Semin Arthritis Rheum."},{"issue":"4","key":"6259_CR3","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.rbre.2017.01.005","volume":"57","author":"AP Marques","year":"2017","unstructured":"Marques AP, Santo AdSdE, Berssaneti AA, Matsutani LA, Yuan SLK. Prevalence of fibromyalgia: Literature review update. Rev Bras Reumatol Engl Ed. 2017;57(4):356\u201363. https:\/\/doi.org\/10.1016\/j.rbre.2017.01.005.","journal-title":"Rev Bras Reumatol Engl Ed."},{"issue":"5","key":"6259_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s40273-014-0137-y","volume":"32","author":"TL Skaer","year":"2014","unstructured":"Skaer TL. Fibromyalgia: disease synopsis, medication cost effectiveness and economic burden. PharmacoEconomics. 2014;32(5):457\u201366. https:\/\/doi.org\/10.1007\/s40273-014-0137-y.","journal-title":"PharmacoEconomics."},{"key":"6259_CR5","doi-asserted-by":"publisher","unstructured":"Giorgi V, Sirotti S, Romano ME, Marotto D, Ablin JN, Salaffi F, et al. Fibromyalgia: one year in review. 2022. Clin Exp Rheumatol. 2022. https:\/\/doi.org\/10.55563\/clinexprheumatol\/if9gk2.","DOI":"10.55563\/clinexprheumatol\/if9gk2"},{"issue":"6","key":"6259_CR6","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/pm\/pnab338","volume":"23","author":"A Goebel","year":"2022","unstructured":"Goebel A, Andersson D, Barker C, Basu N, Bullock C, Bevan S, et al. Research recommendations following the discovery of pain sensitizing IgG autoantibodies in fibromyalgia syndrome. Pain Med. 2022;23(6):1084\u201394. https:\/\/doi.org\/10.1093\/pm\/pnab338.","journal-title":"Pain Med."},{"key":"6259_CR7","doi-asserted-by":"publisher","first-page":"426130-","DOI":"10.1155\/2012\/426130","volume":"2012","author":"E Bellato","year":"2012","unstructured":"Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia DE, et al. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat. 2012;2012:426130-. https:\/\/doi.org\/10.1155\/2012\/426130.","journal-title":"Pain Res Treat."},{"issue":"6","key":"6259_CR8","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","volume":"150","author":"DA Drossman","year":"2016","unstructured":"Drossman DA, Hasler WL. Rome IV; Functional GI disorders: Disorders of gut-brain interaction. Gastroenterology. 2016;150(6):1257\u201361. https:\/\/doi.org\/10.1053\/j.gastro.2016.03.035.","journal-title":"Gastroenterology."},{"key":"6259_CR9","doi-asserted-by":"publisher","unstructured":"Erdrich S, Hawrelak JA, Myers SP, Harnett JE. A systematic review of the association between fibromyalgia and functional gastrointestinal disorders. Therap Adv Gastroenterol. 2020;13. https:\/\/doi.org\/10.1177\/1756284820977402","DOI":"10.1177\/1756284820977402"},{"issue":"12","key":"6259_CR10","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1111\/j.1572-0241.1999.01643.x.11","volume":"94","author":"AD Sperber","year":"1999","unstructured":"Sperber AD, Atzmon Y, Neumann L, Weisberg I, Shalit Y, Abu-Shakrah M, et al. Fibromyalgia in the irritable bowel syndrome: Studies of prevalence and clinical implications. Am J Gastroenterol. 1999;94(12):3541\u20136. https:\/\/doi.org\/10.1111\/j.1572-0241.1999.01643.x.11.","journal-title":"Am J Gastroenterol."},{"key":"6259_CR11","doi-asserted-by":"publisher","first-page":"110119","DOI":"10.1016\/j.mehy.2020.110119","volume":"143","author":"MZ \u00dc\u00e7\u00fcnc\u00fc","year":"2020","unstructured":"\u00dc\u00e7\u00fcnc\u00fc MZ, \u00c7oruhAkyol B, Toprak D. The early diagnosis of fibromyalgia in irritable bowel syndrome patients. Med Hypotheses. 2020;143:110119. https:\/\/doi.org\/10.1016\/j.mehy.2020.110119.","journal-title":"Med Hypotheses."},{"issue":"2","key":"6259_CR12","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1053\/j.gastro.2020.10.058","volume":"160","author":"RAT Mars","year":"2021","unstructured":"Mars RAT, Frith M, Kashyap PC. Functional gastrointestinal disorders and the microbiome\u2014What is the best strategy for moving microbiome-based therapies for functional gastrointestinal disorders into the clinic? Gastroenterology. 2021;160(2):538\u201355. https:\/\/doi.org\/10.1053\/j.gastro.2020.10.058.","journal-title":"Gastroenterology."},{"key":"6259_CR13","doi-asserted-by":"publisher","unstructured":"Minerbi A, Gonzalez E, Brereton NJB, Anjarkouchian A, Dewar K, Fitzcharles MA, Chevalier S, Shir Y. Altered microbiome composition in individuals with fibromyalgia. Pain. 2019;160(11):2589-602. https:\/\/doi.org\/10.1097\/j.pain.0000000000001640.","DOI":"10.1097\/j.pain.0000000000001640"},{"issue":"1","key":"6259_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12891-020-03201-9","volume":"21","author":"S Erdrich","year":"2020","unstructured":"Erdrich S, Hawrelak JA, Myers SP, Harnett JE. Determining the association between fibromyalgia, the gut microbiome and its biomarkers: A systematic review. BMC Musculoskelet Disord. 2020;21(1):181. https:\/\/doi.org\/10.1186\/s12891-020-03201-9.","journal-title":"BMC Musculoskelet Disord."},{"issue":"12","key":"6259_CR15","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3390\/nu9121303","volume":"9","author":"A Ticinesi","year":"2017","unstructured":"Ticinesi A, Lauretani F, Milani C, Nouvenne A, Tana C, Del Rio D, et al. Aging gut microbiota at the cross-road between nutrition, physical frailty, and sarcopenia: Is there a gut\u2013muscle axis? Nutrients. 2017;9(12):1303.","journal-title":"Nutrients."},{"issue":"24","key":"6259_CR16","doi-asserted-by":"publisher","first-page":"9770","DOI":"10.3390\/ijms21249770","volume":"21","author":"BA Paray","year":"2020","unstructured":"Paray BA, Albeshr MF, Jan AT, Rather IA. Leaky gut and autoimmunity: An intricate balance in individuals health and the diseased state. Int J Mol Sci. 2020;21(24):9770. https:\/\/doi.org\/10.3390\/ijms21249770.","journal-title":"Int J Mol Sci."},{"issue":"10","key":"6259_CR17","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/nm.4185","volume":"22","author":"BO Schroeder","year":"2016","unstructured":"Schroeder BO, B\u00e4ckhed F. Signals from the gut microbiota to distant organs in physiology and disease. Nat Med. 2016;22(10):1079\u201389. https:\/\/doi.org\/10.1038\/nm.4185.","journal-title":"Nat Med."},{"key":"6259_CR18","doi-asserted-by":"publisher","unstructured":"Minerbi A, Gonzalez E, Brereton N, Fitzcharles MA, Chevalier S, Shir Y. Altered serum bile acid profile in fibromyalgia is associated with specific gut microbiome changes and symptom severity. Pain. 2023;164(2):e66-e76. https:\/\/doi.org\/10.1097\/j.pain.0000000000002694.","DOI":"10.1097\/j.pain.0000000000002694"},{"issue":"1","key":"6259_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/1541-4337.12401","volume":"18","author":"N Ma","year":"2019","unstructured":"Ma N, Ma X. Dietary amino acids and the gut-microbiome-immune axis: Physiological metabolism and therapeutic prospects. Compr Rev Food Sci Food Saf. 2019;18(1):221\u201342. https:\/\/doi.org\/10.1111\/1541-4337.12401.","journal-title":"Compr Rev Food Sci Food Saf."},{"key":"6259_CR20","doi-asserted-by":"publisher","unstructured":"Wu W-JH, Zegarra-Ruiz DF, Diehl GE. Intestinal microbes in autoimmune and inflammatory disease. Front Immunol. 2020;11. https:\/\/doi.org\/10.3389\/fimmu.2020.597966","DOI":"10.3389\/fimmu.2020.597966"},{"issue":"4","key":"6259_CR21","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.cell.2016.04.007","volume":"165","author":"T Vatanen","year":"2016","unstructured":"Vatanen T, Kostic Aleksandar D, d\u2019Hennezel E, Siljander H, Franzosa Eric A, Yassour M, et al. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell. 2016;165(4):842\u201353. https:\/\/doi.org\/10.1016\/j.cell.2016.04.007.","journal-title":"Cell."},{"issue":"6","key":"6259_CR22","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/cmi.2018.7","volume":"15","author":"B Li","year":"2018","unstructured":"Li B, Selmi C, Tang R, Gershwin ME, Ma X. The microbiome and autoimmunity: a paradigm from the gut\u2013liver axis. Cell Mol Immunol. 2018;15(6):595\u2013609. https:\/\/doi.org\/10.1038\/cmi.2018.7.","journal-title":"Cell Mol Immunol."},{"issue":"1","key":"6259_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.0219-4810.2002.00003.x","volume":"5","author":"P Klemp","year":"2002","unstructured":"Klemp P, Williams SM, Stansfield SA. Fibromyalgia in Maori and European New Zealanders. Int J Rheum Dis. 2002;5(1):1\u20135. https:\/\/doi.org\/10.1046\/j.0219-4810.2002.00003.x.","journal-title":"Int J Rheum Dis."},{"issue":"4","key":"6259_CR24","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.cgh.2008.12.005","volume":"7","author":"C Almansa","year":"2009","unstructured":"Almansa C, Rey E, Sanchez RG, Sanchez AA, Diaz-Rubio M. Prevalence of functional gastrointestinal disorders in patients with fibromyalgia and the role of psychologic distress. Clin Gastroenterol Hepatol. 2009;7(4):438\u201345. https:\/\/doi.org\/10.1016\/j.cgh.2008.12.005.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"6259_CR25","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology: ATC classification index with DDDs. WHO. 2021. Available from: https:\/\/www.whocc.no\/atc_ddd_index\/."},{"key":"6259_CR26","unstructured":"Australian Food, Supplement and Nutrient Database (AUSNUT). FSANZ. 2011-13. Available from: https:\/\/www.foodstandards.govt.nz\/science\/monitoringnutrients\/ausnut\/ausnutdatafiles\/Pages\/dietarysupplements.aspx."},{"key":"6259_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-60761-411-1_1","volume":"594","author":"B Palmieri","year":"2010","unstructured":"Palmieri B, Sblendorio V. Current status of measuring oxidative stress. Methods Mol Biol. 2010;594:3\u201317. https:\/\/doi.org\/10.1007\/978-1-60761-411-1_1. (Humana Press).","journal-title":"Methods Mol Biol."},{"issue":"6","key":"6259_CR28","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1080\/02640414.2020.1840755","volume":"39","author":"KM Quinn","year":"2021","unstructured":"Quinn KM, Cox AJ, Roberts LA, Briskey D, Minahan C. Reliability of a point-of-care device to determine oxidative stress in whole blood before and after acute exercise: A practical approach for the applied sports sciences. J Sports Sci. 2021;39(6):673\u201382. https:\/\/doi.org\/10.1080\/02640414.2020.1840755.","journal-title":"J Sports Sci."},{"key":"6259_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02640414.2020.1840755","volume":"2019","author":"A Hatch","year":"2019","unstructured":"Hatch A, Horne J, Toma R, Twibell BL, Somerville KM, Pelle B, et al. A robust metatranscriptomic technology for population-scale studies of diet, gut microbiome, and human health. Int J Genomics. 2019;2019:1\u20139. https:\/\/doi.org\/10.1080\/02640414.2020.1840755.","journal-title":"Int J Genomics."},{"key":"6259_CR30","doi-asserted-by":"publisher","unstructured":"Banavar G, Ogundijo O, Toma R, Rajagopal S, Lim YK, Tang K, et al. The salivary metatranscriptome as an accurate diagnostic indicator of oral cancer. NPJ Genomic Medicine. 2021;6(1). https:\/\/doi.org\/10.1038\/s41525-021-00257-x.","DOI":"10.1038\/s41525-021-00257-x"},{"issue":"4","key":"6259_CR31","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2144\/btn-2020-0088","volume":"69","author":"R Toma","year":"2020","unstructured":"Toma R, Duval N, Pelle B, Parks MM, Gopu V, Torres PJ, et al. A clinically validated human capillary blood transcriptome test for global systems biology studies. Biotechniques. 2020;69(4):289\u2013301. https:\/\/doi.org\/10.2144\/btn-2020-0088.","journal-title":"Biotechniques."},{"issue":"1","key":"6259_CR32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1042\/cs0710071","volume":"71","author":"DG Maxton","year":"1986","unstructured":"Maxton DG, Bjarnason I, Reynolds AP, Catt SD, Peters TJ, Menzies IS. Lactulose 51Cr-labelled ethylenediaminetetra-acetate, l-rhamnose and polyethyleneglycol 500 as probe markers for assessment in vivo of human intestinal permeability. Clin Sci (Lond). 1986;71(1):71\u201380. https:\/\/doi.org\/10.1042\/cs0710071.","journal-title":"Clin Sci (Lond)."},{"key":"6259_CR33","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1136\/gutjnl-2019-318427","volume":"68","author":"M Camilleri","year":"2019","unstructured":"Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut. 2019;68:1516\u201326. https:\/\/doi.org\/10.1136\/gutjnl-2019-318427.","journal-title":"Gut."},{"issue":"8","key":"6259_CR34","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/rheumatology\/ken140","volume":"47","author":"A Goebel","year":"2008","unstructured":"Goebel A, Buhner S, Schedel R, Lochs H, Sprotte G. Altered intestinal permeability in patients with primary fibromyalgia and in patients with complex regional pain syndrome. Rheumatology. 2008;47(8):1223\u20137. https:\/\/doi.org\/10.1093\/rheumatology\/ken140.","journal-title":"Rheumatology."},{"issue":"6","key":"6259_CR35","doi-asserted-by":"publisher","first-page":"e99256","DOI":"10.1371\/journal.pone.009925634","volume":"9","author":"IR Sequeira","year":"2014","unstructured":"Sequeira IR, Lentle RG, Kruger MC, Hurst RD. Standardising the lactulose mannitol test of gut permeability to minimise error and promote comparability. PLOS ONE. 2014;9(6):e99256. https:\/\/doi.org\/10.1371\/journal.pone.009925634.","journal-title":"PLOS ONE."},{"issue":"9","key":"6259_CR36","doi-asserted-by":"publisher","first-page":"e401","DOI":"10.1111\/j.1365-2982.2012.01969.x","volume":"24","author":"IR Sequeira","year":"2012","unstructured":"Sequeira IR, Lentle RG, Kruger MC, Hurst RD. The effect of aspirin and smoking on urinary excretion profiles of lactulose and mannitol in young women: toward a dynamic, aspirin augmented, test of gut mucosal permeability. Neurogastroenterol Motil. 2012;24(9):e401\u201311. https:\/\/doi.org\/10.1111\/j.1365-2982.2012.01969.x.","journal-title":"Neurogastroenterol Motil."},{"issue":"4","key":"6259_CR37","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1136\/ard.2003.011502","volume":"63","author":"M Pimentel","year":"2004","unstructured":"Pimentel M, Wallace D, Hallegua D, Chow E, Kong Y, Park S, et al. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann Rheum Dis. 2004;63(4):450\u20132. https:\/\/doi.org\/10.1136\/ard.2003.011502.","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"6259_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/ueg2.12133","volume":"10","author":"HF Hammer","year":"2022","unstructured":"Hammer HF, Fox MR, Keller J, Salvatore S, Basilisco G, Hammer J, et al. European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Mot. United European Gastroenterol J. 2022;10(1):15\u201340. https:\/\/doi.org\/10.1002\/ueg2.12133.","journal-title":"United European Gastroenterol J."},{"key":"6259_CR39","doi-asserted-by":"publisher","unstructured":"Erdrich S, Tan ECK, Hawrelak JA, Myers SP, Harnett J. Hydrogen-methane breath testing results influenced by oral hygiene. Sci Rep. 2020;11(1). https:\/\/doi.org\/10.1038\/s41598-020-79554-x.","DOI":"10.1038\/s41598-020-79554-x"},{"issue":"1","key":"6259_CR40","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0016-5085(91)90475-z","volume":"101","author":"A Strocchi","year":"1991","unstructured":"Strocchi A, Ellis C, Levitt MD. Reproducibility of measurements of trace gas concentrations in expired air. Gastroenterology. 1991;101(1):175\u20139. https:\/\/doi.org\/10.1016\/0016-5085(91)90475-z.","journal-title":"Gastroenterology."},{"key":"6259_CR41","unstructured":"QuinTron. BreathTracker SC operator manual. Milwaukee, WI: QuinTron Instrument Company, Inc.; 2019. p. 19."},{"issue":"6","key":"6259_CR42","first-page":"391","volume":"41","author":"PJ Phillips","year":"2012","unstructured":"Phillips PJ. Oral glucose tolerance testing. Aust J Gen Pract. 2012;41(6):391\u20133 (https:\/\/www.racgp.org.au\/afp\/2012\/june\/oral-glucose-tolerance-testing).","journal-title":"Aust J Gen Pract."},{"issue":"1","key":"6259_CR43","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000430981","volume":"92","author":"D Enko","year":"2015","unstructured":"Enko D, Kriegsh\u00e4user G, Kimbacher C, Stolba R, Mangge H, Halwachs-Baumann G. Carbohydrate malabsorption and putative carbohydrate-specific small intestinal bacterial overgrowth: Prevalence and diagnostic overlap observed in an Austrian outpatient center. Digestion. 2015;92(1):32\u20138. https:\/\/doi.org\/10.1159\/000430981.","journal-title":"Digestion."},{"issue":"4","key":"6259_CR44","doi-asserted-by":"publisher","first-page":"R120","DOI":"10.1186\/ar2830","volume":"11","author":"RM Bennett","year":"2009","unstructured":"Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. 2009;11(4):R120-R. https:\/\/doi.org\/10.1186\/ar2830.","journal-title":"Arthritis Res Ther."},{"issue":"5","key":"6259_CR45","first-page":"728","volume":"18","author":"CS Burckhardt","year":"1991","unstructured":"Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol. 1991;18(5):728\u201333 (PMID: 1865419).","journal-title":"J Rheumatol."},{"issue":"6","key":"6259_CR46","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1053\/j.gastro.2016.02.014","volume":"150","author":"OS Palsson","year":"2016","unstructured":"Palsson OS, Whitehead WE, van Tilburg MAL, Chang L, Chey W, Crowell MD, et al. Development and validation of the Rome IV diagnostic questionnaire for adults. Gastroenterology. 2016;150(6):1481\u201391. https:\/\/doi.org\/10.1053\/j.gastro.2016.02.014.","journal-title":"Gastroenterology."},{"issue":"5","key":"6259_CR47","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1007\/BF02064187","volume":"40","author":"DA Drossman","year":"1995","unstructured":"Drossman DA, Li Z, Toner BB, Diamant NE, Creed FH, Thompson D, et al. Functional bowel disorders. A multicenter comparison of health status and development of illness severity index. Dig Dis Sci. 1995;40(5):986\u201395. https:\/\/doi.org\/10.1007\/BF02064187.","journal-title":"Dig Dis Sci."},{"issue":"4","key":"6259_CR48","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/j.1572-0241.2000.01977.xoi","volume":"95","author":"AD Sperber","year":"2000","unstructured":"Sperber AD, Carmel S, Atzmon Y, Weisberg I, Shalit Y, Neumann L, et al. Use of the Functional Bowel Disorder Severity Index (FBDSI) in a study of patients with the irritable bowel syndrome and fibromyalgia. Am J Gastroenterol. 2000;95(4):995\u20138. https:\/\/doi.org\/10.1111\/j.1572-0241.2000.01977.xoi.","journal-title":"Am J Gastroenterol."},{"issue":"10","key":"6259_CR49","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1177\/0333102419840777","volume":"39","author":"HA van der Meer","year":"2019","unstructured":"van der Meer HA, Visscher CM, Vredeveld T, Nijhuis van der Sanden MW, HhEngelbert R, Speksnijder CM. The diagnostic accuracy of headache measurement instruments: A systematic review and meta-analysis focusing on headaches associated with musculoskeletal symptoms. Cephalalgia. 2019;39(10):1313\u201332. https:\/\/doi.org\/10.1177\/0333102419840777.","journal-title":"Cephalalgia."},{"issue":"1","key":"6259_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS).","year":"2018","unstructured":"The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211. https:\/\/doi.org\/10.1177\/0333102417738202.","journal-title":"Cephalalgia."},{"key":"6259_CR51","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.genhosppsych.2015.11.005","volume":"39","author":"F Plummer","year":"2016","unstructured":"Plummer F, Manea L, Trepel D, McMillan D. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. Gen Hosp Psychiatry. 2016;39:24\u201331. https:\/\/doi.org\/10.1016\/j.genhosppsych.2015.11.005.","journal-title":"Gen Hosp Psychiatry."},{"key":"6259_CR52","doi-asserted-by":"crossref","unstructured":"Hays RD, Stewart AL. Sleep measures. In: Stewart AL, Ware JEJ, editors. Measuring functioning and well-being: The medical outcomes study approach. Duke University Press: Duke University Press; 1992. p. 235\u201359. https:\/\/doi.org\/10.7249\/CB361.","DOI":"10.7249\/CB361"},{"issue":"1","key":"6259_CR53","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/00005650-199401000-00004","volume":"32","author":"CA McHorney","year":"1994","unstructured":"McHorney CA, Ware JE, Lu JFR, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994;32(1):40\u201366. https:\/\/doi.org\/10.1097\/00005650-199401000-00004.","journal-title":"Med Care."},{"key":"6259_CR54","unstructured":"Hays RD, Sherbourne CD, Mazel R. User's manual for the medical outcomes study (MOS) core measures of health-related quality of life. Santa Monica, CA. : RAND Corporation; 1995. Available from https:\/\/www.rand.org\/pubs\/monograph_reports\/MR162.html"},{"key":"6259_CR55","unstructured":"Petersen PE, Baez RJ, World Health Organization. Oral health surveys: Basic methods. 5th ed. Geneva: World Health Organization; 2013. Available from https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/97035\/97"},{"key":"6259_CR56","doi-asserted-by":"publisher","first-page":"e70642","DOI":"10.3897\/rio.7.e70642","volume":"7","author":"A Bernstein","year":"2021","unstructured":"Bernstein A, Moore R, Rhee L, Aronson D, Katz D. A digital dietary assessment tool may help identify malnutrition and nutritional deficiencies in hospitalized patients. Res Ideas Outcomes. 2021;7:e70642. https:\/\/doi.org\/10.3897\/rio.7.e70642.","journal-title":"Res Ideas Outcomes."}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-023-06259-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-023-06259-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-023-06259-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T07:04:37Z","timestamp":1677481477000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-023-06259-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,27]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["6259"],"URL":"https:\/\/doi.org\/10.1186\/s12891-023-06259-3","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,27]]},"assertion":[{"value":"13 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the New Zealand Health and Disability Ethics Committee (HDEC) No: 20\/CEN\/197. All participants provide written informed consent to participate. The study is registered with the Australia and New Zealand Clinical Trial Registry (ANZCTR). Registration number: ACTRN12620001337965, and WHO Universal Trial Number: U1111-1258-5108","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SE owns and operates the breath testing facility at the study site. MV is co-founder and research director of Viome Life Sciences. No other authors have any competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}